T43.222A Poisoning by selective serotonin reuptake inhibitors, intentional self-harm, initial encounter

Name of the Condition

• Poisoning by selective serotonin reuptake inhibitors, intentional self-harm, initial encounter

Summary

This code describes an intentional self-harm poisoning resulting from exposure to selective serotonin reuptake inhibitors (SSRIs), a class of antidepressant medications. The term "initial encounter" indicates this is the first time the patient is receiving care for this poisoning. SSRIs are commonly used to treat depression, anxiety, and other mood disorders, and intentional self-harm may involve overdose or misuse of these medications.

Causes

Intentional self-harm poisoning by SSRIs typically results from deliberate overdose, such as taking more than the prescribed dose with the intent to cause harm. It may also occur due to misuse of the medication, including intentional ingestion of incorrect doses or combinations with other substances. The underlying cause is the patient's intentional act to self-poison.

Risk Factors

• History of mental health conditions, such as depression or suicidal ideation.
• Previous attempts at self-harm or suicide.
• Access to SSRIs without supervision or secure storage.
• Concurrent use of other medications or substances that may enhance the effects of SSRIs.
• Lack of social support or access to mental health resources.

Symptoms

• Nausea, vomiting, or abdominal pain.
• Dizziness, drowsiness, or confusion.
• Rapid heart rate or changes in blood pressure.
• Tremors, seizures, or muscle rigidity.
• Agitation, anxiety, or mood changes.
• In severe cases, respiratory depression or coma.

Diagnosis

Diagnosis is based on clinical presentation, medication history, and the nature of the exposure. Healthcare providers assess for signs of intentional self-harm, including patient statements or evidence of deliberate ingestion. Laboratory tests may confirm SSRI levels, and imaging or other studies may be used to evaluate complications. The "initial encounter" designation indicates this is the first episode of care for this poisoning.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing the underlying intent. This may include activated charcoal to reduce absorption, supportive care for respiratory or cardiac issues, and monitoring for complications. Psychological evaluation and intervention are critical to address the self-harm behavior and prevent recurrence.

Prognosis and Follow-Up

Prognosis depends on the severity of the poisoning and the timeliness of treatment. Early intervention improves outcomes, but severe cases may result in long-term complications. Follow-up care includes ongoing mental health support, medication management, and monitoring for recurrence of self-harm behaviors.

Complications

• Respiratory depression or failure.
• Cardiac arrhythmias or heart problems.
• Seizures or neurological damage.
• Kidney or liver injury from toxin accumulation.
• Psychological complications, such as increased suicidal ideation.

Lifestyle & Prevention

• Secure storage of medications to prevent access.
• Regular mental health check-ins and therapy.
• Education on proper medication use and dosing.
• Support systems for managing stress or emotional distress.
• Avoidance of alcohol or other substances that may interact with SSRIs.

When to Seek Professional Help

Seek immediate medical attention if there are signs of overdose, such as confusion, drowsiness, or difficulty breathing. Contact a mental health professional if there are thoughts of self-harm or suicidal ideation, even without physical symptoms.

Tips for Medical Coders

This code is used for the initial encounter of intentional self-harm poisoning by SSRIs. Document the intent (intentional self-harm) and the fact that this is the first episode of care. Ensure clinical notes support the diagnosis, including details of the exposure and any contributing factors. Avoid using this code for accidental or undetermined intent poisonings.